Abstract
Compounds inhibiting LpxC in the lipid A biosynthetic pathway are promising leads for novel antibiotics against multidrug-resistant Gram-negative pathogens. We report the syntheses and structural and biochemical characterizations of LpxC inhibitors based on a diphenyl-diacetylene (1,4-diphenyl-1,3-butadiyne) threonyl-hydroxamate scaffold. These studies provide a molecular interpretation for the differential antibiotic activities of compounds with a substituted distal phenyl ring as well as the absolute stereochemical requirement at the C2, but not C3, position of the threonyl group.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amidohydrolases / antagonists & inhibitors*
-
Amidohydrolases / metabolism
-
Amino Acid Sequence
-
Anti-Bacterial Agents / chemical synthesis*
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology
-
Binding Sites
-
Computer Simulation
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Escherichia coli / enzymology
-
Escherichia coli Proteins / antagonists & inhibitors*
-
Escherichia coli Proteins / metabolism
-
Microbial Sensitivity Tests
-
Molecular Sequence Data
-
Protein Structure, Tertiary
-
Structure-Activity Relationship
Substances
-
Anti-Bacterial Agents
-
Enzyme Inhibitors
-
Escherichia coli Proteins
-
Amidohydrolases
-
UDP-3-O-acyl-N-acetylglucosamine deacetylase